Glaucoma Open-Angle Primary: Clinical Trials

10 trials for Glaucoma Open-Angle Primary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 2 Not applicable, 2 Phase 4, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1
Phase 42Terminated 1, Unknown 1
Phase 11Completed 1
Phase 21Completed 1
Phase 31Recruiting 1

Follow Glaucoma Open-Angle Primary: new trials by email Literature Review of Glaucoma Open-Angle Primary trials Research Report on Glaucoma Open-Angle Primary

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Acute Effect of Exercise Type And Timing on Ambulatory Blood Pressure and Intra-Ocular Pressure in Individuals With Glaucoma (The ACHIEVE-project).
Exercise - Glaucoma Open-Angle Primary, Hypertension
Not applicableRecruitingKU Leuven602026-07-312026-10-29
[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
TFC-003, TFC-003-R1, TFC-003-R2+TFC-003-R3 - Glaucoma Open-Angle Primary, Ocular Hypertension
Phase 3RecruitingKukje Pharma1882025-12-092026-06-23
GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study
Glaucoma Open-Angle Primary, Ocular Hypertension
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS602025-10-012025-10-07
Open-Label Study of Safety of H1337 in Healthy Volunteers
H-1337 1.0% - Glaucoma Open-Angle Primary, Ocular Hypertension
Phase 1CompletedD. Western Therapeutics Institute, Inc.172024-09-162025-02-11
Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
H-1337 0.6%, H-1337 1.0%, H-1337 Placebo - Glaucoma Open-Angle Primary, Ocular Hypertension
Phase 2CompletedD. Western Therapeutics Institute, Inc.2012023-08-282025-08-27
OCTA Study of Choroidal Vasculature in Open Angle Glaucoma Patients
OCTA - Glaucoma Open-Angle Primary
CompletedFederico II University572022-02-012022-07-25
Analysis of Conjunctival Changes as Indicators for Ab-interno Gelatin Microstent Implantation Surgery Outcomes
XEN45 Gel stent, Trabeculectomy - Glaucoma, Glaucoma Open-Angle Primary
Not applicableCompletedHospital Clinic of Barcelona392021-01-012024-01-09
Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for Glaucoma Patients
Phacoemulsification+ Endoscopic cyclophotocoagulation (ECP) laser - Glaucoma Open-Angle Primary, Cataract
Phase 4UnknownGuy's and St Thomas' NHS Foundation Trust1602020-03-152020-03-04
Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy
Mitomycin C - Glaucoma Open-Angle Primary, Glaucoma
Phase 4TerminatedUniversity of California, Los Angeles192019-03-302024-01-05
Monitoring of the IOP After SLT Using iCare Home
Glaucoma Open-Angle Primary, Pseudo Exfoliation Syndrome
UnknownSt. Erik Eye Hospital602017-10-032021-05-12

Narrower conditions

Glaucoma, Open-Angle (10)  ·  Ocular Hypertension (4)  ·  Glaucoma (3)  ·  Cataract (1)  ·  Exfoliation Syndrome (1)  ·  Hypertension (1)  ·  Motor Activity (1)

Broader conditions

Eye Diseases (10)  ·  Glaucoma (7)  ·  Ocular Hypertension (6)  ·  Behavior (1)  ·  Cardiovascular Diseases (1)  ·  Iris Diseases (1)  ·  Lens Diseases (1)  ·  Uveal Diseases (1)  ·  Vascular Diseases (1)

Interventions

Exercise (1)  ·  High-Intensity Interval Training (1)  ·  Lasers (1)  ·  Mitomycin (1)  ·  Trabeculectomy (1)

Sponsors

D. Western Therapeutics Institute, Inc. (2)  ·  Federico II University (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Guy's and St Thomas' NHS Foundation Trust (1)  ·  Hospital Clinic of Barcelona (1)  ·  KU Leuven (1)  ·  Kukje Pharma (1)  ·  St. Erik Eye Hospital (1)  ·  University of California, Los Angeles (1)

Countries

United States (3)  ·  Belgium (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

El-Roy Dixon, MD (1)  ·  Enping Chen, MD Ph D (1)  ·  Marta Pazos, MD, PhD (1)

Results publications

PMID 41042361